Completed from United Kingdom
Honestly, this course was a great boost for my pharmacovigilance skills. I signed up because I wanted to get a better grip on signal detection, and the lessons on data mining tools were spot on. The instructor’s real‑world examples—like handling a batch recall scenario—made the content feel practical. The PDFs were clear and the video quality was solid, though I wish there were a few more interactive quizzes. Still, I walked away with the ability to draft risk management plans and feel more confident in my role at a UK biotech firm.
The Certificado Profesional En Farmacovigilancia (Avanzado) exceeded my expectations. The curriculum aligned perfectly with my goal of mastering adverse event reporting for my role at a pharmaceutical company. I especially appreciated the module on ICH E2E guidelines, which gave me a clear framework for preparing safety reports. The case‑study exercises, such as drafting a Periodic Safety Update Report, were directly applicable to my daily tasks. The course materials were up‑to‑date and included downloadable templates that I now use regularly. Overall, the learning experience was smooth, interactive, and highly relevant—I'm confident this certification will accelerate my career growth.
I’m thrilled with what I learned! The advanced certification gave me hands‑on experience with electronic reporting systems, and I even completed a simulated EudraVigilance submission during the course. The instructors were enthusiastic and broke down complex regulatory requirements into bite‑size pieces, which helped me achieve my goal of leading the pharmacovigilance team at my hospital. The downloadable cheat‑sheets and real case studies (like the vaccine safety monitoring project) were pure gold. I feel fully equipped to handle global safety assessments now—highly recommend this program!
The course offered a detailed and thorough exploration of advanced pharmacovigilance topics. I was particularly impressed by the segment on causality assessment, where we practiced using the WHO‑UMC criteria on actual case reports. This practical approach helped me meet my objective of improving our adverse event documentation process at a South African research institute. The study materials were comprehensive, featuring up‑to‑date regulatory guidelines and well‑structured slide decks. While the pacing was a bit fast in the later modules, the depth of content and the final capstone project on creating a comprehensive safety dossier made the experience valuable and directly applicable to my work.
